kentucky glp-1 side effect legal team Ozempic Lawyer in kentucky glp-1 side effect lawyer

State-licensed pharmacies must stop making most compounded semaglutide (copies of Novo Nordisks Wegovy and Ozempic) by April 22, and larger outsourcing pharmacies by May 22, or when district court rules on a pending injuction whichever is first

In June 2023, Pfizer announced the progress of its oral late-stage glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate toward first clinical development for the potential treatment of adults with obesity and Type 2 diabetes mellitus (T2DM)

Dual Agonists Under Investigation Tirzepatide (Mounjaro) was approved by the FDA on May 13, 2022 for the treatment of type 2 diabetes in adults, making it the first and only GIP/GLP-1 receptor agonist

And this is why medications like Ozempic, Wegovy, and Mounjaro have also been getting a lot of attention